Company Overview More
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
Trade HeatSearch HeatNews Heat
SymbolLatest Price% Chg

Loading...

KTTA Pasithea Therapeutics

4.010+0.020+0.50%
Close 11/26 16:54 ET
4.270+0.26+6.48%
Post Mkt Price 11/26 16:59 ET
High
4.390
Open
3.800
Turnover
23.58M
Low
3.800
Prev.Close
3.990
Volume
5.75M
Market Cap
52.97M
P/E(TTM)
0.00
52Wk High
8.500
Shares
13.21M
P/E
0.00
52Wk Low
2.100
H Mkt Cap
19.25M
Bid-Ask Ratio
-80.00%
Historical High
8.500
H Shares
4.80M
Vol. Ratio
0.22
Historical Low
2.100
Dividend TTM
--
Div Yield TTM
--
P/B
3.22
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
119.79%
Amplitude
14.79%
Avg Price
4.100
Min Trading Unit
1
Float Market Cap
19.25M
Bid-Ask Ratio
-80.00%
Historical High
8.500
Float
4.80M
Vol. Ratio
0.22
Historical Low
2.100
Dividend TTM
--
P/B
3.22
Dividend LFY
--
Turnover Ratio
119.79%
Amplitude
14.79%
Avg Price
4.100
Min Trading Unit
1
Price Forecast

Loading...

News